Linden Advisors’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.34M Hold
600,000
0.04% 253
2025
Q4
$6.29M Hold
600,000
0.04% 226
2025
Q3
$6.21M Hold
600,000
0.04% 201
2025
Q2
$6.18M Hold
600,000
0.04% 206
2025
Q1
$6.05M Buy
+600,000
New +$6.03M 0.04% 180

Other funds holding TDAC

Linden Advisors's TDAC Position: Q1 2026 in Review

Linden Advisors held its Translational Development Acquisition Corp (TDAC) position steady in Q1 2026 at 600,000 shares worth $6.34M. The position accounts for 0.04% of the portfolio, ranked #253.

Linden Advisors first reported a position in TDAC in Q1 2025 and has held it in 5 quarters since. 48 funds tracked by Wall St. Rank hold TDAC as of Q1 2026.

  • Linden Advisors held 600,000 shares of Translational Development Acquisition Corp worth $6.34M as of Q1 2026.
  • Linden Advisors left its Translational Development Acquisition Corp share count unchanged in Q1 2026.
  • Translational Development Acquisition Corp made up 0.04% of Linden Advisors's portfolio in Q1 2026, its #253 holding.
  • Linden Advisors first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 5 quarters since.
  • 48 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q1 2026.

Based on Linden Advisors's 13F filing for Q1 2026, filed 15 May 2026.